Foss, Frank

Publication with MATCHING institution:

Yang S, Chang Y, Hazoor S, ..., Dong H (2021) Modular Design of Supramolecular Ionic Peptides with Cell-Selective
Membrane Activity. ChemBioChem. [IF=0.691, Cited=0, 34506664].
Kormányos A, Hossain MS, Ghadimkhani G, ..., Rajeshwar K (2016) Flavin Derivatives with Tailored Redox Properties:
Synthesis, Characterization, and Electrochemical Behavior. Chemistry - A European Journal. [IF=0.899, Cited=3, 27243969].
Leghissa A, Hildenbrand ZL, Foss F, ..., Schug KA (2017) Determination of cannabinoids from a surrogate hops matrix
using multiple reaction monitoring gas chromatography with triple quadrupole mass spectrometry. Journal of Separation
Science. [IF=0.869, Cited=13, 29094798].
Barnes JS, Foss F, Foss FW, ..., Schug KA (2013) Thermally accelerated oxidative degradation of quercetin using
continuous flow kinetic electrospray-ion trap-time of flight mass spectrometry. Journal of the American Society for Mass
Spectrometry. [IF=0.827, Cited=17, 23934548].
Crowell J, Crowell JK, Sardar S, ..., Pierce BS (2016) Non-chemical proton-dependent steps prior to O2-activation limit
Azotobacter vinelandii 3-mercaptopropionic acid dioxygenase (MDO) catalysis. Archives of Biochemistry and Biophysics.
[IF=0.874, Cited=9, 27311613].
Morrow WP, Sardar S, Thapa P, ..., Pierce BS (2017) Thiol dioxygenase turnover yields benzothiazole products from
2-mercaptoaniline and O₂-dependent oxidation of primary alcohols. Archives of Biochemistry and Biophysics.
[IF=0.874, Cited=3, 28826737].
Pierce BS, Schmittou AN, York NJ, ..., Lockart MM (2024) Improved resolution of 3-mercaptopropionate dioxygenase active
site provided by ENDOR spectroscopy offers insight into catalytic mechanism. Journal of Biological Chemistry. [IF=1.122,
Cited=0, 38395308].
Joseph E, Le CQ, Nguyen T, ..., Johnson-Winters K (2016) Evidence of Negative Cooperativity and Half-Site Reactivity
within an F420-Dependent Enzyme: Kinetic Analysis of F420H2:NADP(+) Oxidoreductase. Biochemistry. [IF=0.753, Cited=5, 26811861].
Thapa P, Hazoor S, Chouhan B, ..., Foss F (2020) Flavin Nitroalkane Oxidase Mimics Compatibility with NOx/TEMPO
Catalysis: Aerobic Oxidization of Alcohols, Diols, and Ethers. Journal of Organic Chemistry. [IF=0.885, Cited=1, 32569467].
Patel DC, Breitbach ZS, Woods RM, ..., Armstrong DW (2016) Gram Scale Conversion of R-BINAM to R-NOBIN. Journal of
Organic Chemistry. [IF=0.885, Cited=6, 26741793].
Thapa P, Corral E, Sardar S, ..., Foss F (2019) Isoindolinone Synthesis: Selective Dioxane-Mediated Aerobic Oxidation of
Isoindolines. Journal of Organic Chemistry. [IF=0.885, Cited=4, 30571120].
Thapa P, Palacios PM, Tran T, ..., Foss F (2020) 1,2-Disubstituted Benzimidazoles by the Iron Catalyzed Cross-
Dehydrogenative Coupling of Isomeric o-Phenylenediamine Substrates. Journal of Organic Chemistry. [IF=0.885,
Cited=5, 31928002].
Nguyen TTM, Hazoor S, Vuong T, ..., La Plante E (2024) Synthesis of Metastable Calcium Carbonate Using Long-Chain
Bisphosphonate Molecules. ACS applied materials & interfaces. [IF=1.429, Cited=0, 38830119].
Thapa P, Byrnes NK, Denisenko AA, ..., Foss F (2021) Demonstration of Selective Single-Barium Ion Detection with Dry
Diazacrown Ether Naphthalimide Turn-on Chemosensors. ACS Sensors. [IF=1.539, Cited=4, 33400506].
Corder AL, Subedi BP, Zhang S, ..., Pierce BS (2013) Peroxide-shunt substrate-specificity for the Salmonella typhimurium
O2-dependent tRNA modifying monooxygenase (MiaE). Biochemistry. [IF=0.753, Cited=6, 23906247].
Subedi BP, Corder AL, Zhang S, ..., Pierce BS (2014) Steady-state kinetics and spectroscopic characterization of enzyme-
tRNA interactions for the non-heme diiron tRNA-monooxygenase, MiaE. Biochemistry. [IF=0.753, Cited=5, 25453905].
Fang Z, Wanigasekara MSK, Yepremyan A, ..., Chowdhury SM (2021) Mass Spectrometry-Cleavable Protein N-Terminal Tagging
Strategy for System-Level Protease Activity Profiling. Journal of the American Society for Mass Spectrometry. [IF=0.827,
Cited=0, 34928623].
Yang SH, Wang EH, Gurak JA, ..., Schug KA (2013) Affinity mesh screen materials for selective extraction and analysis of
antibiotics using transmission mode desorption electrospray ionization mass spectrometry. Langmuir. [IF=0.927, Cited=5, 23721220].
Chen S, Hossain MS, Foss F (2012) Organocatalytic Dakin oxidation by nucleophilic flavin catalysts. Organic Letters.
[IF=1.091, Cited=16, 22587606].
Chen S, Foss F (2012) Aerobic organocatalytic oxidation of aryl aldehydes: flavin catalyst turnover by Hantzsch's ester.
Organic Letters. [IF=1.091, Cited=17, 23016963].
Thapa P, Arnquist I, Byrnes N, ..., Woodruff K (2019) Barium Chemosensors with Dry-Phase Fluorescence for Neutrinoless
Double Beta Decay. Scientific Reports. [IF=1.312, Cited=5, 31641206].
Hossain MS, Le CQ, Joseph E, ..., Foss F (2015) Convenient synthesis of deazaflavin cofactor FO and its activity in
F(420)-dependent NADP reductase. Organic and Biomolecular Chemistry. [IF=0.77, Cited=12, 25827330].
Pandiri M, Hossain MS, Foss F, ..., Paz Y (2016) Enhanced photocatalytic activity of a self-stabilized synthetic flavin
anchored on a TiO2 surface. Physical Chemistry Chemical Physics. [IF=0.906, Cited=2, 27346787].
Pandiri M, Shaham-Waldmann N, Hossain MS, ..., Paz Y (2016) Correction: Enhanced photocatalytic activity of a self-
stabilized synthetic flavin anchored on a TiO2 surface. Physical Chemistry Chemical Physics. [IF=0.906, Cited=0, 27509005].
Haefner J, Navarro KE, Guenette R, ..., White JT (2024) Demonstration of event position reconstruction based on
diffusion in the NEXT-white detector. European Physical Journal C. [IF=1.301, Cited=0, 38784120].

Publication with MISMATCHING institution:

Foss F, Kuzel TM (1999) Novel treatment approaches for cutaneous T-cell lymphoma. None. [IF=None, Cited=2, 9891869].
Foss F, Saleh MN, Krueger JG, ..., Murphy JR (1998) Diphtheria toxin fusion proteins. None. [IF=None, Cited=24, 9670613].
Foss F, Snyder AH, Davis MD, ..., Macdonald TL (2006) Synthesis and biological evaluation of gamma-aminophosphonates as
potent, subtype-selective sphingosine 1-phosphate receptor agonists and antagonists. Bioorganic and Medicinal Chemistry.
[IF=0.86, Cited=89, 17113298].
Foss F, Mathews TP, Kharel Y, ..., Macdonald TL (2009) Synthesis and biological evaluation of sphingosine kinase
substrates as sphingosine-1-phosphate receptor prodrugs. Bioorganic and Medicinal Chemistry. [IF=0.86, Cited=13, 19632123].
Foss F, Clemens JJ, Davis MD, ..., Macdonald TL (2005) Synthesis, stability, and implications of phosphothioate agonists
of sphingosine-1-phosphate receptors. Bioorganic and Medicinal Chemistry Letters. [IF=0.704, Cited=15, 16125386].
Sweeney EB, Foss F, Murphy JR, vanderSpek JC (1998) Interleukin 7 (IL-7) receptor-specific cell killing by DAB389 IL-7:
a novel agent for the elimination of IL-7 receptor positive cells. Bioconjugate Chemistry. [IF=0.921, Cited=8, 9548535].
Quinn JR, Foss F, Venkataraman L, ..., Breslow R (2007) Single-molecule junction conductance through diaminoacenes.
Journal of the American Chemical Society. [IF=2.573, Cited=18, 17488083].
Quinn JR, Foss F, Venkataraman L, Breslow R (2007) Oxidation potentials correlate with conductivities of aromatic
molecular wires. Journal of the American Chemical Society. [IF=2.573, Cited=17, 17887757].
Zhao H, Foss F, Breslow R (2008) Artificial enzymes with thiazolium and imidazolium coenzyme mimics. Journal of the
American Chemical Society. [IF=2.573, Cited=11, 18763766].
Schneebeli S, Kamenetska M, Foss F, ..., Breslow R (2010) The electrical properties of biphenylenes. Organic Letters.
[IF=1.091, Cited=9, 20722383].
Sun Q, Zhu R, Foss F, Macdonald TL (2008) In vitro metabolism of a model cyclopropylamine to reactive intermediate:
insights into trovafloxacin-induced hepatotoxicity. Chemical Research in Toxicology. [IF=0.994, Cited=14, 18298092].
Nadeau M, Perreault S, Seropian S, ..., Cooper DL (2015) The use of basiliximab-infliximab combination for the treatment
of severe gastrointestinal acute GvHD. Bone Marrow Transplantation. [IF=1.303, Cited=11, 26479982].
Depner C, Zum Buttel H, Böğürcü N, ..., Acker-Palmer A (2016) EphrinB2 repression through ZEB2 mediates tumour invasion
and anti-angiogenic resistance. Nature Communications. [IF=3.268, Cited=46, 27470974].
Foss F, Gorgun G, Miller KB (2002) Extracorporeal photopheresis in chronic graft-versus-host disease. Bone Marrow
Transplantation. [IF=1.303, Cited=50, 12040467].
Foss F, DiVenuti GM, Chin K, ..., Miller KB (2005) Prospective study of extracorporeal photopheresis in steroid-
refractory or steroid-resistant extensive chronic graft-versus-host disease: analysis of response and survival
incorporating prognostic factors. Bone Marrow Transplantation. [IF=1.303, Cited=107, 15852025].
Cross JV, Rady JM, Foss F, ..., Templeton DJ (2009) Nutrient isothiocyanates covalently modify and inhibit the
inflammatory cytokine macrophage migration inhibitory factor (MIF). Biochemical Journal. [IF=0.852, Cited=36, 19723024].
Horwitz S, Coiffier B, Foss F, ..., Pro B (2015) Utility of ¹⁸fluoro-deoxyglucose positron emission tomography for
prognosis and response assessments in a phase 2 study of romidepsin in patients with relapsed or refractory peripheral
T-cell lymphoma. Annals of Oncology. [IF=8.208, Cited=6, 25605745].
Foss F (2001) Interleukin-2 fusion toxin: targeted therapy for cutaneous T cell lymphoma. Annals of the New York Academy
of Sciences. [IF=1.878, Cited=27, 11594570].
Wang A, Hornick N, Lim Y, ..., Damsky W (2020) Interleukin-17 blockade downregulates NOD2 in skin and may promote
paradoxical sarcoidosis. Journal of the European Academy of Dermatology and Venereology. [IF=2.044, Cited=0, 32249470].
Hornick N, Wang A, Lim Y, ..., Damsky W (2020) Development or worsening of sarcoidosis associated with IL-17 blockade
for psoriasis. Journal of the European Academy of Dermatology and Venereology. [IF=2.044, Cited=2, 32277505].
Cowan RA, Scarisbrick JJ, Zinzani PL, ..., Medley MC (2021) Efficacy and safety of mogamulizumab by patient baseline
blood tumour burden: a post hoc analysis of the MAVORIC trial. Journal of the European Academy of Dermatology and
Venereology. [IF=2.044, Cited=10, 34273208].
Alcindor T, Gorgun G, Miller KB, ..., Foss F (2001) Immunomodulatory effects of extracorporeal photochemotherapy in
patients with extensive chronic graft-versus-host disease. Blood. [IF=2.983, Cited=63, 11520818].
Foss F, Ihde DC, Breneman DL, ..., Ghosh BC (1992) Phase II study of pentostatin and intermittent high-dose recombinant
interferon alfa-2a in advanced mycosis fungoides/Sézary syndrome. Journal of Clinical Oncology. [IF=6.449, Cited=35, 1453206].
Foss F, Ihde DC, Linnoila IR, ..., Bastian A (1994) Phase II trial of fludarabine phosphate and interferon alfa-2a in
advanced mycosis fungoides/Sézary syndrome. Journal of Clinical Oncology. [IF=6.449, Cited=50, 7931473].
Foss F, Koc Y, Stetler-Stevenson MA, ..., Sausville EA (1994) Costimulation of cutaneous T-cell lymphoma cells by
interleukin-7 and interleukin-2: potential autocrine or paracrine effectors in the Sézary syndrome. Journal of Clinical
Oncology. [IF=6.449, Cited=24, 8113839].
Olsen E, Duvic M, Frankel A, ..., Nichols J (2001) Pivotal phase III trial of two dose levels of denileukin diftitox for
the treatment of cutaneous T-cell lymphoma. Journal of Clinical Oncology. [IF=6.449, Cited=302, 11208829].
Foss F (2000) DAB(389)IL-2 (ONTAK): a novel fusion toxin therapy for lymphoma. None. [IF=None, Cited=53, 11707818].
Foss F (2000) An oncologist's approach to therapy for cutaneous T-cell lymphoma. None. [IF=None, Cited=2, 11707857].
Foss F, Bacha P, Osann KE, ..., Kuzel T (2001) Biological correlates of acute hypersensitivity events with DAB(389)IL-2
(denileukin diftitox, ONTAK) in cutaneous T-cell lymphoma: decreased frequency and severity with steroid premedication.
None. [IF=None, Cited=66, 11707845].
Foss F (2000) Activity of pentostatin (Nipent) in cutaneous T-cell lymphoma: single-agent and combination studies.
Seminars in Oncology. [IF=1.319, Cited=0, 10877054].
Foss F (2000) Combination therapy with purine nucleoside analogs. Oncology. [IF=0.338, Cited=0, 10887642].
Foss F (2000) DAB(389)IL-2 (denileukin diftitox, ONTAK): a new fusion protein technology. None. [IF=None, Cited=0, 11707860].
Foss F, Veillette A, Sartor O, ..., Bolen JB (1989) Alterations in the expression of pp60c-src and p56lck associated
with butyrate-induced differentiation of human colon carcinoma cells. None. [IF=None, Cited=0, 2476706].
Foss F, Borkowski TA, Gilliom M, ..., Woodworth T (1994) Chimeric fusion protein toxin DAB486IL-2 in advanced mycosis
fungoides and the Sezary syndrome: correlation of activity and interleukin-2 receptor expression in a phase II study.
Blood. [IF=2.983, Cited=0, 8080984].
Foss F, Sausville EA (1995) Prognosis and staging of cutaneous T-cell lymphoma. Hematology/Oncology Clinics of North
America. [IF=1.055, Cited=0, 8522481].
Foss F, Kuzel TM (1995) Experimental therapies in the treatment of cutaneous T-cell lymphoma. Hematology/Oncology
Clinics of North America. [IF=1.055, Cited=0, 8522489].
Foss F, Dickinson E, Hills M, ..., Ebrahim S (1996) Missed opportunities for the prevention of cardiovascular disease
among British hypertensives in primary care. British Journal of General Practice. [IF=1.854, Cited=0, 8945793].
Foss F, Raubitscheck A, Mulshine JL, ..., Carrasquillo JA (1998) Phase I study of the pharmacokinetics of a
radioimmunoconjugate, 90Y-T101, in patients with CD5-expressing leukemia and lymphoma. Clinical Cancer Research.
[IF=2.156, Cited=0, 9829731].

Publication with MISSING institution:

Graham SJ, Sharpe RW, Steinberg SM, ..., Foss F (1993) Prognostic implications of a bone marrow histopathologic
classification system in mycosis fungoides and the Sézary syndrome. Cancer. [IF=2.097, Cited=9, 8334625].
Bunn PA, Foss F (1996) T-cell lymphoma cell lines (HUT102 and HUT78) established at the National Cancer Institute:
history and importance to understanding the biology, clinical features, and therapy of cutaneous T-cell lymphomas (CTCL)
and adult T-cell leukemia-lymphomas (ATLL). None. [IF=None, Cited=27, 8806090].
Foss F, Horneff J, Longo DL, Messerschmidt GL (1983) Cerebrospinal fluid rhinorrhea as a complication of malignant
lymphoma. American Journal of Medicine. [IF=1.05, Cited=4, 6859057].
Yuan SC, Foss F, O'Connor M, ..., Moss J (1999) Effects of intravenous methylnaltrexone on opioid-induced gut motility
and transit time changes in subjects receiving chronic methadone therapy: a pilot study. Pain. [IF=3.151, Cited=54, 10568873].
Huang X, Foss F, Foss FW, ..., Dasgupta PK (2011) Multilayer chitosan-based open tubular capillary anion exchange column
with integrated monolithic capillary suppressor. Analytica Chimica Acta. [IF=1.176, Cited=5, 22027141].
Sun Q, Zhu R, Foss F, Macdonald TL (2007) Mechanisms of trovafloxacin hepatotoxicity: studies of a model
cyclopropylamine-containing system. Bioorganic and Medicinal Chemistry Letters. [IF=0.704, Cited=7, 17976985].
Bobbitt JM, Li L, Carlton DD, ..., Schug KA (2012) Diastereoselective discrimination of lysine-alanine-alanine peptides
by zwitterionic cinchona alkaloid-based chiral selectors using electrospray ionization mass spectrometry. Journal of
Chromatography A. [IF=1.02, Cited=5, 22935729].
Bubley GJ, Xu J, Kupiec N, ..., Patierno SR (1996) Effect of DNA conformation on cisplatin adduct formation. Biochemical
Pharmacology. [IF=1.155, Cited=14, 8615910].
Seibel NL, Funa K, Dmitrovsky E, ..., Kirsch IR (1987) Application of RNA-RNA tissue in situ hybridization in an
analysis of a patient with leukemia. Human Pathology. [IF=1.137, Cited=7, 3817798].
Demierre MF, Foss F, Koh HK (1997) Proceedings of the International Consensus Conference on Cutaneous T-cell Lymphoma
(CTCL) Treatment Recommendations. Boston, Massachusetts, Oct. 1 and 2, 1994. Journal of the American Academy of
Dermatology. [IF=1.982, Cited=18, 9091480].
Saleh MN, LeMaistre CF, Kuzel TM, ..., Nichols JC (1998) Antitumor activity of DAB389IL-2 fusion toxin in mycosis
fungoides. Journal of the American Academy of Dermatology. [IF=1.982, Cited=67, 9674399].
Howard M, Carrubba C, Foss F, ..., Guinness M (1987) Interposed abdominal compression-CPR: its effects on parameters of
coronary perfusion in human subjects. Annals of Emergency Medicine. [IF=1.879, Cited=31, 3813159].
Nichols J, Foss F, Kuzel TM, ..., Schwartz G (1997) Interleukin-2 fusion protein: an investigational therapy for
interleukin-2 receptor expressing malignancies. European Journal of Cancer. [IF=2.253, Cited=33, 9166099].
Argiris A, Heald P, Kuzel T, ..., Murren JR (2001) Phase II trial of 9-aminocamptothecin as a 72-h infusion in cutaneous
T-cell lymphoma. Investigational New Drugs. [IF=0.78, Cited=5, 11561692].
Shaughnessy PJ, Bolwell BJ, van Besien K, ..., Abhyankar S (2009) Extracorporeal photopheresis for the prevention of
acute GVHD in patients undergoing standard myeloablative conditioning and allogeneic hematopoietic stem cell
transplantation. Bone Marrow Transplantation. [IF=1.303, Cited=21, 19915634].
Cinamon G, Zachariah MA, Lam OM, ..., Cyster JG (2007) Follicular shuttling of marginal zone B cells facilitates antigen
transport. Nature Immunology. [IF=4.23, Cited=319, 18037889].
French LE, Alcindor T, Shapiro M, ..., Foss F (2002) Identification of amplified clonal T cell populations in the blood
of patients with chronic graft-versus-host disease: positive correlation with response to photopheresis. Bone Marrow
Transplantation. [IF=1.303, Cited=27, 12379890].
Miller KB, Roberts TF, Chan G, ..., Foss F (2004) A novel reduced intensity regimen for allogeneic hematopoietic stem
cell transplantation associated with a reduced incidence of graft-versus-host disease. Bone Marrow Transplantation.
[IF=1.303, Cited=43, 14990986].
Urbano A, Koc Y, Foss F (1998) Arginine butyrate downregulates p210 bcr-abl expression and induces apoptosis in chronic
myelogenous leukemia cells. Leukemia. [IF=2.198, Cited=5, 9639422].
Kaye FJ, Bunn PA, Steinberg SM, ..., Foss F (1989) A randomized trial comparing combination electron-beam radiation and
chemotherapy with topical therapy in the initial treatment of mycosis fungoides. New England Journal of Medicine.
[IF=17.194, Cited=222, 2594037].
Urbano A, McCaffrey R, Foss F (1998) Isolation and characterization of NUC70, a cytoplasmic, hematopoietic apoptotic
endonuclease. Journal of Biological Chemistry. [IF=1.122, Cited=17, 9857008].
Kuchnio M, Sausville EA, Jaffe ES, ..., Stetler-Stevenson MA (1994) Flow cytometric detection of neoplastic T cells in
patients with mycosis fungoides based on levels of T-cell receptor expression. American Journal of Clinical Pathology.
[IF=1.099, Cited=18, 7801904].
Bogen SA, Pelley D, Charif M, ..., Zucker-Franklin D (1996) Immunophenotypic identification of Sezary cells in
peripheral blood. American Journal of Clinical Pathology. [IF=1.099, Cited=45, 8980349].
Cohen R, Jaffe ES, Stetler-Stevenson MA, ..., Foss F (1994) Bilateral adrenal hemorrhage and adrenal insufficiency in a
patient with lymphomatous adrenal infiltration following administration of a fusion toxin (DAB486 interleukin-2). None.
[IF=None, Cited=2, 7834123].
Powsner RA, Zietman AL, Foss F (1997) Bone marrow suppression after strontium-89 therapy and local radiation therapy in
patients with diffuse marrow involvement. Clinical Nuclear Medicine. [IF=0.662, Cited=3, 9067666].
Evans RN, Foss F (1984) Traumatic hemipelvectomy in combination with traumatic amputation of an upper extremity. None.
[IF=None, Cited=9, 6708157].
Tso P, Rodriguez A, Cooper C, ..., Mighty HE (1992) Sonography in blunt abdominal trauma: a preliminary progress report.
None. [IF=None, Cited=147, 1635104].
Rook AH, Zaki MH, Wysocka M, ..., Sherman ML (2001) The role for interleukin-12 therapy of cutaneous T cell lymphoma.
Annals of the New York Academy of Sciences. [IF=1.878, Cited=28, 11594571].
Awad AS, Ye H, Huang L, ..., Okusa MD (2006) Selective sphingosine 1-phosphate 1 receptor activation reduces ischemia-
reperfusion injury in mouse kidney. American Journal of Physiology - Renal Physiology. [IF=1.073, Cited=168, 16403835].
Cross JV, Foss F, Rady JM, ..., Templeton DJ (2007) The isothiocyanate class of bioactive nutrients covalently inhibit
the MEKK1 protein kinase. BMC Cancer. [IF=1.166, Cited=23, 17894894].
Cheson BD, Vena DA, Foss F, Sorensen JM (1994) Neurotoxicity of purine analogs: a review. Journal of Clinical Oncology.
[IF=6.449, Cited=84, 7931492].
Cohen RB, Abdallah JM, Gray JR, Foss F (1993) Reversible neurologic toxicity in patients treated with standard-dose
fludarabine phosphate for mycosis fungoides and chronic lymphocytic leukemia. Annals of Internal Medicine. [IF=5.157,
Cited=26, 8416307].
Akpek G, Koh HK, Bogen S, ..., Foss F (1999) Chemotherapy with etoposide, vincristine, doxorubicin, bolus
cyclophosphamide, and oral prednisone in patients with refractory cutaneous T-cell lymphoma. Cancer. [IF=2.097,
Cited=0, 10506727].
Vose JM, Cabanillas F, O'Brien S, ..., Foss F (2000) Infectious complications of pentostatin therapy. Oncology.
[IF=0.338, Cited=0, 10887644].
Kamath L, Meydani A, Foss F, Kuliopulos A (2001) Signaling from protease-activated receptor-1 inhibits migration and
invasion of breast cancer cells. Cancer Research. [IF=1.624, Cited=0, 11479236].
Mickley LA, Bates SE, Richert ND, ..., Fojo AT (1989) Modulation of the expression of a multidrug resistance gene
(mdr-1/P-glycoprotein) by differentiating agents. Journal of Biological Chemistry. [IF=1.122, Cited=0, 2572588].
Veillette A, Foss F, Sausville EA, ..., Rosen N (1987) Expression of the lck tyrosine kinase gene in human colon
carcinoma and other non-lymphoid human tumor cell lines. None. [IF=None, Cited=0, 2835736].
Thakur S, Lin HC, Tseng WT, ..., Rabson AB (1994) Rearrangement and altered expression of the NFKB-2 gene in human
cutaneous T-lymphoma cells. Oncogene. [IF=1.523, Cited=0, 8036016].
Rosen ST, Foss F (1995) Chemotherapy for mycosis fungoides and the Sézary syndrome. Hematology/Oncology Clinics of North
America. [IF=1.055, Cited=0, 8522487].
Cheson BD, Foss F, Phillips PH (1995) Clinical Trials Referral Resource: Mycosis Fungoides/Sézary Syndrome. Oncology.
[IF=0.338, Cited=0, 8924374].
Foss F (1997) Missed opportunities for the prevention of cardiovascular disease. British Journal of General Practice.
[IF=1.854, Cited=0, 9101675].
LeMaistre CF, Saleh MN, Kuzel TM, ..., Nichols JC (1998) Phase I trial of a ligand fusion-protein (DAB389IL-2) in
lymphomas expressing the receptor for interleukin-2. Blood. [IF=2.983, Cited=0, 9427692].
Abd-el-Baki J, Stefanato CM, Koh HK, ..., Foss F (1998) Early detection of cutaneous lymphoma. Oncology. [IF=0.338,
Cited=0, 9798206].